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Abstract
Background: It is more and more recognized that hypoxia plays a role in the resistance of cancer
cells to chemotherapy. However, the mechanisms underlying this resistance still need deeper
understanding. The aim of this study was to investigate the effect of hypoxia on this process since
hypoxia is one of the hallmarks of tumor environment.
Results: The effect of hypoxia on the apoptosis induced by etoposide, one drug commonly used
in chemotherapy, was investigated using three different cancer cell lines. Gene expression changes
were also studied in order to delineate the mechanisms responsible for the hypoxia-induced
chemoresistance. We observed that hypoxia differentially influenced etoposide-induced cell death
according to the cancer cell type. While hypoxia inhibited apoptosis in hepatoma HepG2 cells, it
had no influence in lung carcinoma A549 cells and further enhanced it in breast cancer MCF-7 cells.
Etoposide increased p53 activity in all cell lines while hypoxia alone decreased it only in HepG2
cells. Hypoxia had no influence on the etoposide-induced p53 activity in A549, increased p53
abundance in MCF-7 cells but markedly decreased p53 activity in HepG2 cells. Using low density
DNA arrays to detect the expression of genes involved in the regulation of apoptosis, etoposide
and hypoxia were shown to each influence the expression of numerous genes, many of the ones
influenced by etoposide being p53 target genes. Again, the influence of hypoxia on the etoposide-
induced changes was different according to the cell type.
Conclusion: These results evidenced that there was a striking parallelism between the effect of
hypoxia on the etoposide-induced p53 stabilization as well as p53 target gene expression and its
effect on the etoposide-induced apoptosis according to the cell type. They are very interesting not
only because they provide one possible mechanism for the induction of chemoresistance under
hypoxic conditions in cells like HepG2 but also because they indicate that not all cell types respond
the same way. This knowledge is of importance in designing adequate treatment according to the
type of tumors.
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Introduction
Chemotherapy is an integral component of standard care
for solid tumors. However, recurrence may occur, with a
poor clinical outcome. Some of the primary factors lead-
ing to chemoresistance begin to be understood. Overex-
pression of members of the ABC transporter family (MDR
being the most well known), mutations as well as the
development of therapeutic sanctuaries are well character-
ized to be responsible for drug resistance. Recently, the
influence of hypoxia has also been recognized.
During tumor growth, the central area becomes hypoxic
due to poor access to blood vessels capable of delivering
oxygen [1,2]. Hypoxic regions have been evidenced in a
wide range of cancers [3,4]. Low tumor oxygenation has
been identified as an independent negative prognostic
factor [5,6] and is associated with a higher risk of meta-
static spread. In addition, hypoxia contributes to resist-
ance to radiation therapy and to chemotherapy [7].
Hypoxia may directly induce tumor resistance via depriva-
tion of molecular oxygen needed for some drugs to induce
DNA damage. Indirectly, hypoxia may lead to treatment
resistance by modulating gene expression resulting in
resistance to cell death.
Many of the changes in gene expression observed under
hypoxia are controlled by hypoxia-inducible factor-1
(HIF-1), a transcription factor specifically activated by
oxygen deprivation [8]. HIF-1 is composed of two subu-
nits belonging to the bHLH-PAS family: ARNT which is
constitutively expressed in the nucleus and HIF-1α which
is regulated by hypoxia. In normoxia (20% oxygen), HIF-
1α is hydroxylated on two prolines (residues 564 and
402) by an oxygen-dependent prolyl hydroxylase and on
the asparagine 803 by one oxygen-dependent asparaginyl
hydroxylase, FIH-1. The two hydroxylated prolines are
recognized by the protein pVHL, which is part of an ubiq-
uitin ligase complex, thus targeting the HIF-1α subunit for
degradation by the proteasome [9,10]. The hydroxylation
of the asparagine prevents HIF-1α-CBP/p300 interaction
[11]. In low oxygen conditions, HIF-1α is no longer mod-
ified and is thus stabilized. HIF-1α then translocates into
the nucleus where it dimerizes with ARNT. The active HIF-
1 binds to its specific site called HRE (hypoxia response
element), present in the promoter of target genes. The
products of these target genes (glucose transporter-1,
VEGF and most of the glycolytic enzymes) allow the cell
to adapt to the low oxygen conditions.
If mild hypoxia is rather pro-survival, it must be noted
however that severe or prolonged hypoxia can lead to cell
death, mainly through an apoptotic pathway [12,13].
HIF-1 seems to play a major role in this process by induc-
ing p53 stabilization [14,15], overexpression of pro-apop-
totic proteins such as BNIP3 [16] or HGTD-P [17] as well
as Bax translocation [18].
It is thus apparent that hypoxia can either initiate apopto-
sis and cell death or prevent cell death by provoking adap-
tive response facilitating cell proliferation and tumor
growth [4]. Considering that HIF-1 both induces the
expression of pro-survival and cell death inducing genes,
it is thus crucial to understand the fine tuning regulation
that makes decision between life and death. Similarly, the
influence of hypoxia on apoptosis resistance to radio- and
chemotherapy still needs deeper understanding. The aim
of this study was (i) to investigate the effect of hypoxia on
the apoptosis induced by a drug used in chemotherapy
using three different cancer cell lines and (ii) to define
gene expression changes for each of them, in response to
this drug, under normoxic and hypoxic conditions. Gene
expression patterns were then correlated with the activity
of HIF-1 and p53 in order to define molecular pathways
involved in the cellular response as well as with the apop-
totic profile observed under hypoxic conditions. We used
etoposide as the apoptosis inducer. Etoposide is a topoi-
somerase II inhibitor that induces double strand breaks in
DNA, thus leading to the activation of p53 and apoptosis
[19]. We observed that hypoxia differentially influenced
etoposide-induced cell death according to the cell type
and that p53 may play a role in this process.
Results
Hypoxia differently modulates the etoposide-induced 
apoptosis according to the cell line
Etoposide is known to induce apoptosis through DNA
damage induced p53 activation [19]. We recently evi-
denced that hypoxia could protect HepG2 cells from the
etoposide-induced apoptosis [20]. We then wanted to
investigate whether such an effect was also observed using
other cancer cell lines. We thus compared the effect of
hypoxia on three cancer cell lines originating from differ-
ent organs, all of them containing wild-type p53 : HepG2
from liver, A549 from lung and MCF-7 from breast. It has
to be mentioned that MCF-7 cells are deficient for caspase
3, the main executive caspase. All three cell lines, incu-
bated in the presence of 50 µM etoposide during 16 hours,
did undergo apoptosis as shown by the appearance of the
cleaved active form of caspase 3 (as observed by western
blot), an increase in caspase 3 activity and in PARP cleav-
age (Fig. 1). Hypoxia alone did not induce apoptosis since
no increase in any of these parameters was observed after
16 hours incubation. On the other hand, in HepG2, as
already published [20], hypoxia inhibited the etoposide-
induced apoptosis: a marked decrease in caspase 3 cleav-
age, in caspase 3 activity and in PARP cleavage was
observed (Fig. 1). However, such a protective effect was
not observed for the other cell lines: hypoxia did not
influence etoposide-induced apoptosis in A549 cellsMolecular Cancer 2007, 6:61 http://www.molecular-cancer.com/content/6/1/61
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while it seemed to enhance it in MCF-7 cells. Indeed, the
abundance of PARP cleaved fragment was much higher
when MCF-7 cells were incubated in the presence of
etoposide under hypoxia than under normoxia (Fig. 1C).
Cell apoptosis and cell death were followed for a longer
period of incubation in order to investigate whether the
effect of hypoxia is sustained. Cells were incubated in the
presence of etoposide under normoxic or hypoxic condi-
tions for 40 h (Fig. 2). As an indication for apoptosis,
PARP cleavage was assessed by western blot. Results (Fig.
Effect of hypoxia on the etoposide-induced apoptosis Figure 1
Effect of hypoxia on the etoposide-induced apoptosis. A549, MCF-7 or HepG2 cells were incubated under normoxic (N) or 
hypoxic (H) conditions with or without etoposide (e, 50 µM) for 16 hours.A, procaspase 3 and the 20 kDa long subunit were 
detected in total cell extracts by western blotting, using a specific anti-caspase 3 antibody. a-tubulin was used to assess the total 
amount of proteins loaded on the gel. B, the caspase 3 activity was assayed by measuring free AFC released from the cleavage 
of the caspase 3 substrate Ac-DEVD-AFC. Results are expressed in fluorescence intensity, as means ± 1 SD (n = 3). C, PARP-1 
and cleaved 85 kDa fragment were detected in total cell extracts by western blotting, using a specific anti-PARP-1 antibody. a-
tubulin was used to assess the total amount of proteins loaded on the gel.
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2A) show that PARP cleavage induced by etoposide was
more pronounced after 40 h incubation than after 16 h, in
all three cell lines. Hypoxia prevented etoposide-induced
PARP cleavage in HepG2 cells while it enhanced it in
MCF-7 cells and had no effect in A549 cells. Cell death
was also detected, as evidenced by an increase in LDH
release, but again hypoxia differently influenced etopo-
side-induced cell death according to the cell type, with
similar effects as observed for PARP cleavage. It has to be
noted that hypoxia also induced a slight increase in cell
death after 40 h incubation in A549 and MCF-7 cells. All
together, these results indicate that the effect of hypoxia
was sustained and translated in effect on cell viability.
Hypoxia does not influence etoposide-induced DNA 
damage
Several pathways can influence apoptosis. Since etoposide
induces DNA damage which then turns on p53, we first
studied whether hypoxia could influence the induction of
DNA damage by etoposide or could modulate the rate of
DNA repair. As a surrogate for DNA damage, we followed
phosphorylation on serine 139 of the histone H2AX [21],
by immunofluorescence labeling using an antibody spe-
Effect of hypoxia on the etoposide-induced apoptosis Figure 2
Effect of hypoxia on the etoposide-induced apoptosis. A549, MCF-7 or HepG2 cells were incubated under normoxic (N) or 
hypoxic (H) conditions with or without etoposide (e, 50 µM) for 40 hours. A, PARP-1 and cleaved 85 kDa fragment were 
detected in total cell extracts by western blotting, using a specific anti-PARP-1 antibody. a-tubulin was used to assess the total 
amount of proteins loaded on the gel. B, LDH release was assessed. Results are presented in percentages, as means ± 1 SD (n 
= 3).
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cific for the phosphorylated form of this histone. Cells
were labeled 1 hour after the beginning of this incubation
to evidence the induction of DNA damage by etoposide
and after 16 hour incubation to assess DNA repair. Results
shows that etoposide did induce histone H2AX phospho-
rylation in all three cell lines with HepG2 cells being the
most sensitive [see Additional file 1]. DNA damage were
still present after 16 hour incubation : the intensity of the
labeling seemed weaker than after 1 hour incubation, for
all three cell lines, suggesting DNA repair. Hypoxia did
not influence the effect of etoposide nor the induction of
DNA damage nor their repair.
Etoposide does not affect HIF-1 activation under hypoxia
HIF-1 has been shown to be responsible for an adaptive
response of cells to hypoxia. If etoposide would influence
its activity under hypoxia, this could lead to changes in
cell survival. In order to investigate this possibility, we
measured HIF-1α protein level by western blot and HIF-1
DNA binding activity. The results indicate that hypoxia
did increase HIF-1α protein level and HIF-1 DNA binding
activity in all three cell lines and these effects were not or
very slightly influenced by etoposide (Fig. 3). It is thus not
through modulation of HIF-1 activity that hypoxia affects
etoposide-induced apoptosis according to the cell line.
Hypoxia influences p53 activity differently according to 
the cell line
Etoposide induces cell death through the activation of
p53, which then enhances the expression of pro-apoptotic
genes. Hypoxia is known to modulate p53 protein level
and activity [22]. However, this effect can be different
according to the severity of hypoxia i.e. more severe
hypoxia leads to p53 stabilization [14] while mild
hypoxia does not. Decreased p53 protein level and activity
has also been described for example in HepG2 cells
exposed to 1 % O2 [23]. In order to investigate whether
hypoxia would differently influence etoposide-induced
p53 activation in the three cell lines used here, we studied
the effect of hypoxia on p53 protein level as well as on its
activity.
Figure 4 shows that in all three cell lines, etoposide
induced an increase in p53 protein level as observed by
western blot using two different antibodies (Fig. 4A) or
immunofluorescence staining (Fig. 4B). It also increased
p53 phosphorylation on serine 15 in A549 and HepG2
cells. No phosphorylation was detected in MCF-7 cells.
p53 was mainly localized in the nucleus of stimulated
cells. Hypoxia alone had little effect on p53 protein abun-
dance in A549 and MCF-7 cells, which have a very low
basal level of p53 under basal conditions. On the other
hand, it markedly decreased p53 protein level in HepG2
cells. It has to be noted that, in this cell line, under basal
condition, p53 is expressed at a high level and is mainly
cytosolic. Moreover, hypoxia differentially affected the
etoposide-induced increase in p53 protein level according
to the cell type. It had no effect in A549 cells, induced a
further increase in p53 protein abundance in MCF-7 but
inhibited the effect of etoposide in HepG2 cells. There is a
striking correlation between the effect of hypoxia on p53
protein level and its influence on etoposide-induced
apoptosis. p53 DNA binding activity and actual transcrip-
tional activity were also measured (Fig. 5A and 5B).
Etoposide increased p53 activity in all cell lines while
hypoxia alone decreased it only in HepG2 cells. Hypoxia
had no influence on the etoposide-induced p53 activity in
A549 and MCF-7 cells but markedly decreased it in
Effect of hypoxia and/or etoposide on the HIF-1α protein  level and HIF-1 DNA binding activity Figure 3
Effect of hypoxia and/or etoposide on the HIF-1α protein 
level and HIF-1 DNA binding activity. A549, MCF-7 or 
HepG2 cells were incubated under normoxic (N) or hypoxic 
(H) conditions with or without etoposide (e, 50 µM) for 16 
hours. A, HIF-1α was detected in total cell extracts by west-
ern blotting. a-tubulin was used to assess the total amount of 
proteins loaded on the gel. B, after the incubation, nuclear 
extracts were performed from three independent experi-
ments and hybridized in the ELISA well containing specific 
DNA probes (TransAM assay). Detection was performed 
using an anti-HIF-1α antibody. Results are expressed in 
absorbance (means ± 1 SD, n = 3).
0,0
0,2
0,4
0,6
0,8
1,0
NN eHH eNN eHH eNN eHH e
A549 MCF-7 HepG2
A
b
s
o
r
b
a
n
c
e
A
α-tubulin
HIF-1α
Hypoxia (1% O2)
Etoposide (50 µM)
A549 HepG2 MCF-7
-
-
-
+
+
-
+
+
-
-
-
+
+
-
+
+
+
-
+
+
BMolecular Cancer 2007, 6:61 http://www.molecular-cancer.com/content/6/1/61
Page 6 of 16
(page number not for citation purposes)
Effect of hypoxia on the etoposide-induced p53 stabilization Figure 4
Effect of hypoxia on the etoposide-induced p53 stabilization. A549, MCF-7 or HepG2 cells were incubated under normoxic or 
hypoxic conditions with or without etoposide (50 µM) for 1 or 16 hours. A, p53 was detected in total cell extracts by western 
blotting, using two specific anti-p53 antibodies (a monoclonal and a polyclonal). Phosphorylation of p53 on serine15 was 
revealed using a specific antibody. ERK2 and a-tubulin were used to assess the total amount of proteins loaded on the gel. ND 
= non detected B, after the incubation, cells were fixed, permeabilized and stained for p53 using a specific antibody (green). 
Nuclei were detected with To-Pro-3 (blue). Observation was performed using a confocal microscope with the photomultiplier 
constant.
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HepG2 cells. These results are very similar to the ones
obtained when assessing p53 protein level. The only dif-
ference is that hypoxia further enhanced the etoposide-
induced increase in p53 protein abundance without
repercussion on p53 DNA binding activity or transcrip-
tional activity in MCF-7 cells. One possible explanation is
that hypoxia influenced p53 modification needed for its
stabilization but not all the post-translational modifica-
tions required for its activity (indeed we could not
detected p53 phosphorylation on serine 15 in the pres-
ence of etoposide in MCF-7 cells) or that one co-factor
became limiting.
p53 DNA binding activity is mainly driven by p53 protein
level while its transcriptional activity is regulated not only
by p53 protein level but also by post-translational modi-
fications like phosphorylation and acetylation. The west-
ern blot analysis shown in Figure 4A evidenced that
hypoxia strongly decreased p53 protein level in HepG2
cells. There is a strong correlation between DNA binding
activity and p53 protein level for HepG2 cells. The marked
decrease in p53 protein level and DNA binding activity
was not reflected in the luciferase activity assay, probably
because there is already a quite high basal activity of the
reporter system that is p53 independent (see normoxic
control in A549 and MCF-7 while very low p53 protein
level is detected by western blot) and that is not affected
by hypoxia. The system can thus detect increased p53
activity as in the presence of etoposide but not diminished
p53 activity. It has to be mentioned that hypoxia alone
decreased the expression of several p53 target genes and
decreased the etoposide overexpression of these genes in
HepG2 cells (see results of figures 6 and 7). All together,
these observations indicate that p53 activity is decreased
under hypoxic conditions in HepG2 cells.
Hypoxia and etoposide induce changes in gene expression
The apoptosis induced by etoposide is controlled by
numerous pro- and anti-apoptotic genes. We hypothe-
sized that hypoxia could induce gene expression altera-
tions differentially according to the cell type, that would
then influence the etoposide-induced apoptosis. We thus
compared differences and similarities in gene expression
modifications in both conditions i.e. etoposide under
normoxic and hypoxic conditions in the three cell types.
To investigate the expression of genes that are differen-
tially regulated in these conditions, a low-density DNA
microarray has been used. This microarray comprises 123
capture probes allowing gene expression analysis for a set
of key genes related to apoptosis (DualChip®  human
apoptosis, Eppendorf). Cells were incubated during 16
hours in the presence or in the absence of etoposide at 50
µM under normoxia or hypoxia. Cells were harvested and
total RNA was extracted and reverse transcribed into
cDNA using biotinylated nucleotides. The resulting
cDNAs were hybridized on the microarray and revealed
with a cyanin 3-conjugated anti-biotin antibody. Three
independent experiments were performed for each condi-
tion and each sample was hybridized to three submicroar-
rays represented by the probes spotted in triplicates. The
array data were subjected to a simple algorithm (see Mate-
rials and Methods) to set a lower threshold and to nor-
malize the data using internal standard controls and
house keeping genes. Then, average ratios compared to
normoxia and their standard deviations (S.D.) were calcu-
lated. We ended up with a list of gene transcripts that were
not detected due to their low abundance, detected with no
modification, quantitatively up- or down-regulated and
Effect of hypoxia on the etoposide-induced p53 activation Figure 5
Effect of hypoxia on the etoposide-induced p53 activation. 
A549, MCF-7 or HepG2 cells were incubated under nor-
moxic or hypoxic conditions with or without etoposide (50 
µM) for 1 or 16 hours. A, after the incubation, nuclear 
extracts were performed from three independent experi-
ments and hybridized in the ELISA well containing specific 
DNA probes (TransAM assay). Detection was performed 
using an anti-p53 antibody. Results are expressed in absorb-
ance (means ± 1 SD, n = 3). B, Cells were cotransfected with 
the reporter plasmid pG13-Luc encoding the firefly luciferase 
and the pCMVβ normalization plasmid before being incu-
bated 16 hours under normoxia (N) or hypoxia (H) in the 
presence or absence of etoposide (e, 50 µM). Results are 
expressed as means of the ratio between firefly luciferase 
activity and the β-galactosidase activity ± 1 SD (n = 3).
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Gene expression profiling, for genes involved in regulating apoptosis, in A549, MCF-7 and HepG2 cells incubated with or with- out etoposide under normoxic or hypoxic conditions Figure 6
Gene expression profiling, for genes involved in regulating apoptosis, in A549, MCF-7 and HepG2 cells incubated with or with-
out etoposide under normoxic or hypoxic conditions. Please refer to supplementary data [Additional file 2] for results 
obtained for the 62 genes for which there was a significant variation in expression for at least one of the conditions. Cells were 
incubated under normoxic (N) or hypoxic (H) conditions with or without etoposide (e, 50 µM) for 16 hours before RNA 
extraction, reverse-transcription and cDNA hybridization, as described in Materials and Methods. Each value is the average of 
three ratio values calculated from three independent experiments ± 1 S.D. Mean ratios indicate a fold-increase or decrease in 
gene expression. Qualitative values are given with + or - signs (according to the inserted table). The red vertical bars corre-
spond to undetected cDNA. Duplicates or unique value are noted with a red 2 or 1 behind the corresponding column.
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qualitatively up-or down-regulated. Genes were sorted in
the latter category when the fluorescent signal was either
completely saturated or lower than 2.5× the local back-
ground in one of the experimental conditions.
All the changes in gene expression are presented in the
supplementary table [see Additional file 2]. Some of the
genes upregulated by etoposide, are genes known to be
p53 target genes (GADD45, BAX, MDM2) while some of
the genes upregulated by hypoxia alone are genes known
to be HIF-1 target genes (BNIP3, ALDOA). The increased
expression of the genes induced by hypoxia did not seem
to be affected by the presence of etoposide. These results
are coherent with the fact that etoposide did not influence
HIF-1 activity under hypoxia (see Fig. 3). Two families of
genes for which changes in gene expression could be of
interest were outlined. The first list identified 7 genes
whose products are directly involved in switching on or
off the apoptosis process (Fig. 6). Of note are BAX and
BAK  whose expression was significantly increased by
etoposide in all cell lines. Moreover, hypoxia influenced
this increase differentially according to the cell type: it had
no effect on A549 cells, inhibited the etoposide-induced
increased in BAX  and  BAK  expression in HepG2 cells
while further enhanced it in MCF-7 cells. These expression
profiles are similar to the ones for p53 protein level and
for apoptotic level. There are also genes upregulated both
by etoposide and by hypoxia alone (e.g. MCL1) and the
combined effect of both conditions was additive in
HepG2 cells but not in the two other cell types. Finally,
the expression of BIRC5  (encoding survivin) was
decreased under hypoxic conditions, and to a much larger
extent in the presence of etoposide. The effect of both was
additive in HepG2 cells. The second list of genes includes
genes whose product is involved in regulating cell cycle :
in general, etoposide increased the expression of cell cycle
inhibitors (e.g. CDKN1A  which encodes p21) while
decreasing the expression of genes coding for kinases or
transcription factors needed for progression through the
cell cycle (CDK2, CDC2, CDK4, E2F1) (Fig. 8). These
observations are true for all three cell lines. In most cases,
hypoxia alone did not influence the expression of these
genes and did not influence the effect of etoposide.
The fact that our data are in good agreement with previous
studies reporting modifications in HIF-1 target gene
expression during hypoxia as well as in p53 target genes in
the presence of etoposide already validates the DNA
Comparison of the results obtained with real time RT-PCR and DNA microarrays analyses for aldolase, BAK1, CDNK1A,  GADD45A, GAPDH, GPX1, and MCL1 genes Figure 7
Comparison of the results obtained with real time RT-PCR and DNA microarrays analyses for aldolase, BAK1, CDNK1A, 
GADD45A, GAPDH, GPX1, and MCL1 genes. After the incubation, total RNA was extracted, submitted to reverse transcription 
and then to amplification in the presence of SYBR Green and specific primers. RPL13A was used as the house keeping gene for 
data normalization. For real-time RT-PCR results, data are given in fold-induction. For DNA microarray results, mean ratios 
indicate a fold-increase or decrease in gene expression. They are highlighted in blue if statistically non significant, in yellow for 
quantitative data and in green for qualitative data, given with + or - signs (according to the inserted table).
A549 MCF-7 HepG2
N Ne H He N Ne H He N Ne H He
aldolase DNA microarray 1 0,89 1,64 1,57 1 0,77 1,83 1,97 1 0,86 2,02 2
real-time RT-PCR 1 0,98 3,45 2,22 1 1,07 3,72 3,18 1 0,73 1,88 1,74
Bak1 DNA microarray 1 + ND + 1 2,8 1,03 3,68 1 2,71 0,84 +
real-time RT-PCR 1 2,78 0,89 2,79 1 1,29 0,62 1,23 1 2,87 0,6 1,81
CDKN1A DNA microarray 1 +++ 1,09 14,11 1 11,47 1,15 9,5 1 +++ 0,69 2,4
real-time RT-PCR 1 33,08 2,22 25,62 1 10,46 0,69 10,56 1 4,59 0,54 2,56
GADD45A DNA microarray 1 8,34 1,02 6,36 1 ++ ND +++ 1 ++ 3,07 6,01
real-time RT-PCR 1 14,19 1,84 18,53 1 7,03 1,6 10,08 1 3,49 2,25 4,33
GAPDH DNA microarray 1 0,93 1,11 1,01 1 0,86 1,64 2,08 1 0,96 1,79 1,73
real-time RT-PCR 1 1,08 2,64 1,91 1 1,21 4,11 2,84 1 0,97 2,07 2,01
GPX1 DNA microarray 1 3,19 0,66 2,82 1 ND ND ND 1 2,86 0,79 1,39
real-time RT-PCR 1 4,19 0,97 3,64 1 0,89 0,86 1,95 1 2,78 0,69 1,25
MCL-1 DNA microarray 1 1,51 1,2 1,78 1 1,57 0,81 1,45 1 2,84 2,44 5,36
real-time RT-PCR 1 2,11 2,52 3,92 1 1,7 0,99 1,64 1 2,3 2,42 6,6
ND = non detected
non significantly different from N
quantitative
qualitative with + < 5
5 . 1<+ +<1 0
10.1 < +++Molecular Cancer 2007, 6:61 http://www.molecular-cancer.com/content/6/1/61
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microarray used in this study. In order to further validate
our data, we also performed SYBR Green quantitative real
time PCR assays for some selected genes. Values obtained
for a set of 7 genes that were up-regulated or down-regu-
lated in response to at least one condition were confirmed
(Fig. 7). For these genes, we found a very good correlation
between relative transcript abundance data obtained by
DNA microarray and by real time RT-PCR.
Protein levels of three p53 target genes (p21, Bax and
mdm2) as well as of Bak were then assessed (Fig. 9). There
is a very good correlation between CDKN1A mRNA and
p21 protein level: etoposide markedly increased both in
all three cell lines while hypoxia alone decreased both
only in HepG2 cells. Hypoxia did not influence the etopo-
side-induced increase in p21 protein level in A549 cells,
strongly decreased it in HepG2 cells and seemed to further
enhance it in MCF-7 cells. Similar observations can be
made for Bak, with a good correlation between mRNA
and protein levels but not for Bax and mdm2. BAX mRNA
expression profile is similar to the ones for CDKN1A and
BAK  mRNA. Bax protein levels followed mRNA abun-
Gene expression profiling, for genes involved in regulating cell cycle, in A549, MCF-7 and HepG2 cells incubated with or with- out etoposide under normoxic or hypoxic conditions Figure 8
Gene expression profiling, for genes involved in regulating cell cycle, in A549, MCF-7 and HepG2 cells incubated with or with-
out etoposide under normoxic or hypoxic conditions. Please refer to supplementary data [Additional file 2] for results 
obtained for the 62 genes for which there was a significant variation in expression for at least one of the conditions. Cells were 
incubated under normoxic (N) or hypoxic (H) conditions with or without etoposide (e, 50 µM) for 16 hours before RNA 
extraction, reverse-transcription and cDNA hybridization, as described in Materials and Methods. Each value is the average of 
three ratio values calculated from three independent experiments ± 1 S.D. Mean ratios indicate a fold-increase or decrease in 
gene expression. Qualitative values are given with + or - signs (according to the inserted table). The red vertical bars corre-
spond to undetected cDNA. Duplicates or unique value are noted with a red 2 or 1 behind the corresponding column.
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dance in A549 and MCF-7 cells but not in HepG2 cells.
Indeed, in these cells, etoposide induced a decrease in Bax
protein abundance while hypoxia had no effect. There is a
correlation between all these results and the evolution of
p53 protein level, but not with HIF-1α protein level.
Finally, in all three cell lines, etoposide increased by sev-
eral folds mdm2 mRNA level with no influence of hypoxia.
On the other hand, an increase in mdm2 protein level in
the presence of etoposide was observed in A549 and in
MCF-7 cells while there was a decrease in HepG2 cells.
Under hypoxic conditions, the protein was much less
abundant in the three cell types even if an increase in
mRNA level was observed in the presence of etoposide. All
these results indicate that post-transcriptional events are
involved in regulating mdm2 protein level similarly in the
three cell lines while a regulation specific to the HepG2
cells is involved for the regulation of Bax, Bak and p21
expression.
Discussion
Hypoxia is described to induce resistance of cancer cells to
radio- and chemotherapy. In addition to decrease oxygen
availability needed for radiation or for some of the chem-
ical drugs to induce damage to the cells, hypoxia also
modifies gene expression, thus rendering the cells less sen-
sitive to these treatments. The exact mechanisms triggered
by hypoxia that lead to resistance to apoptosis are not
known, neither are the genes involved in this resistance
that are turned on. The results presented in this work evi-
denced that not all cell types are protected by hypoxia. If
Effect of hypoxia and/or etoposide on p21 (A), Bak, Bax and mdm2 (B) protein levels Figure 9
Effect of hypoxia and/or etoposide on p21 (A), Bak, Bax and mdm2 (B) protein levels. A549, MCF-7 or HepG2 cells were incu-
bated under normoxic (N) or hypoxic (H) conditions with or without etoposide (e, 50 µM) for 16 hours. p21, Bak, Bax and 
mdm2 were detected in total cell extracts by western blotting, using specific antibodies. a-tubulin was used to assess the total 
amount of proteins loaded on the gel.
A
A549 MCF-7 HepG2
B
-
-
-
+
+
-
+
+
-
-
-
+
+
-
+
+
Hypoxia (1% O2)
Etoposide (50 µM)
-
-
-
+
+
-
+
+
p21
D-tubulin
A549 MCF-7 HepG2
Hypoxia (1% O2)
Etoposide (50 µM)
-
-
-
+
+
-
+
+
-
-
-
+
+
-
+
+
-
-
-
+
+
-
+
+
Bak
Bax
mdm2
D-tubulinMolecular Cancer 2007, 6:61 http://www.molecular-cancer.com/content/6/1/61
Page 12 of 16
(page number not for citation purposes)
the apoptosis induced by etoposide is inhibited in HepG2
cells, oxygen deficiency did not influence the etoposide-
induced cell death in A549 cells and even further
enhanced cell death induced in MCF-7 cells. Indeed,
etoposide-induced increase in caspase 3 activity and PARP
cleavage was differentially modulated by hypoxia accord-
ing to the cell type. Etoposide triggers apoptosis through
the induction of double strand DNA damage that then
lead to p53 stabilization. Our results indicate that hypoxia
does not influence the induction, nor the reparation of
DNA damage. However, there was a striking parallelism
between the effect of hypoxia on the etoposide-induced
p53 stabilization and its effect on the etoposide-induced
apoptosis according to the cell type.
Numerous reports have evidenced positive or negative
effects of hypoxia on p53. The first one was the work of An
et al [14] that showed that under severe hypoxic condi-
tions, HIF-1α can directly interact with p53 leading to its
stabilization. Further ones also showed that hypoxia also
led to p53 stabilization probably through a displacement
of p53 from mdm2 by HIF-1α. It must be noted that even
if stabilized in these conditions, p53 is often not transcrip-
tionally active [24]. On the other hand, other works
showed no effect or even a decrease in p53 protein level
under hypoxia [25] and a careful analysis of the experi-
mental conditions used in the several studies revealed that
p53 is stabilized under severe or prolonged hypoxia while
mild hypoxia does not influence or even decreases p53
protein level [12,22]. Difference in HIF-1α phosphoryla-
tion status according to the severity of hypoxia could
explain why it binds to p53 only in severe hypoxic condi-
tions [26]. On the other hand, p53 phosphorylation by
CK2 targeting this protein for degradation by the proteas-
ome system in mild conditions has been proposed to
explain its lower abundance in HepG2 cells under these
conditions [23]. If it is known that according to the degree
of hypoxia, opposite effects can be observed on p53 pro-
tein level, there has been no report until now evidencing
opposite effects according to the cell type exposed to the
same decrease in pO2, as we observed here. Chi et al [27]
elegantly demonstrated that different cell types (endothe-
lial or epithelial vs smooth muscle cells) respond differ-
ently to hypoxia through the induction of a different
panel of hypoxic-responsive genes. However, no p53
responsive gene was described in their study. The mecha-
nisms underlying the specific effects of hypoxia in cancer
cells in relation to apoptosis remain to be investigated.
The differential effect of hypoxia on the etoposide-
induced increase in p53 protein level in the three cell lines
studied here is reflected on its activity. Indeed, in HepG2
cells, we observed a decrease in p53 DNA binding activity,
in its transcriptional activity measured with the use of a
reporter system and in the relative mRNA abundance of its
target genes (e.g. CDKN1A, BAX, BAK, GADD45, GPX1),
as measured using the DNA microarray. Similarly, further
increase in the etoposide-induced in the expression of the
mRNA for four of these target genes (GPX1 mRNA was not
detected in MCF-7 cells) was evidenced in MCF-7 cells.
The reason why such an increase was not observed using
the reporter system is not known, but may involve a satu-
ration of the luciferase expression or limiting amount of
cofactor(s). Finally, hypoxia did not influence the etopo-
side-induced increase in p53 activity nor in the expression
of its target genes in A549 cells.
All together, these results suggest that hypoxia inhibits or
aggravates the etoposide-induced apoptosis through inhi-
bition or further activation of the etoposide-induced
increase in p53 transcriptional activity. p53 activity leads
to the overexpression of pro-apoptotic genes like BAX and
BAK, which can then be responsible for the induction of
apoptosis. By modulating their expression, hypoxia
directly modulates cell death. It has to be noted that pro-
tein expression does not always follow mRNA levels. If it
was the case for Bak, Bax protein abundance in HepG2
involves post-transcriptional mechanisms. Secondly, pro-
apoptotic gene transcription is not the only way by which
p53 induces apoptosis. This protein can also triggers the
intrinsic apoptotic pathway through direct protein-pro-
tein interaction notably with Bak and Bcl-2 [28]. Such a
mechanism may also be switched on by hypoxia in MCF-
7 cells. Indeed, immunofluorescence studies (Fig. 4)
showed that, in these cells, p53 was not only localized in
the nucleus but also in the cytoplasm. Further investiga-
tion is needed to confirm this hypothesis.
In addition to prevent p53-dependent transcription of
Bax, hypoxia also interferes with Bax expression/function
in a transcriptionally independent manner. Indeed, Kim
et al [29] show that hypoxia blocked Bax translocation
from the cytosol to the outer mitochondrial membrane,
hence preventing TRAIL-induced apoptosis. Moreover,
oxygen deprivation also results in a decreased Bax protein
expression in different cell lines, in a proteasome-inde-
pendent manner, probably through a reduction in global
translation efficiency [30]. In this report, Bax decreased
expression led to cell resistance to drug-induced apoptosis
under hypoxia.
The regulation of p21 expression is complex. p21 mRNA
has been described to be upregulated by DNA damaging
agents and under hypoxic conditions probably through
different mechanisms. Krieg et al [31] demonstrated that
p53 binds to the p21 promoter in both conditions but is
only active to enhance p21 gene expression in the pres-
ence of DNA damaging agents. p53 seems not to be
responsible for the enhanced p21 expression under
hypoxia. On the other hand, Koshiji et al [32] showed thatMolecular Cancer 2007, 6:61 http://www.molecular-cancer.com/content/6/1/61
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p21 overexpression under hypoxia is due to HIF-1α : HIF-
1α counteracts c-myc repression of p21 expression under
these conditions. Both p53 and HIF-1α are thus probably
involved in our experimental conditions, probably differ-
ently according to the conditions (etoposide versus
hypoxia, or both together).
A clear correlation between the hypoxia-induced protec-
tion against etoposide-induced apoptosis and the effect of
hypoxia on p53 was evidence in HepG2 cells in this work.
It is thus probably by inhibiting the expression of p53-
dependent pro-apoptotic genes that hypoxia is protective.
These results are in good accordance with a recent study
published by Wang et al [33] that shows that hypoxia
could protect cisplatin-induced tubular cell apoptosis in a
HIF-1-independent way but via suppression of p53 func-
tions.
Etoposide modulates the expression of numerous genes at
least in part through a p53-dependent mechanism. How-
ever, various changes in gene expression are also observed
in p53-deficient cells as observed in HL-60 leukemic cells
[34], indicating that other mechanisms are involved. In
this study, etoposide induced a decrease in the expression
of several cell cycle regulating genes. This decrease is sim-
ilar in all the three cell lines and was not modulated by
hypoxia, suggesting that it is probably independent of p53
activity.
The results of this study are very interesting not only
because they provide one possible mechanism explaining
chemoresistance under hypoxic conditions in cells like
HepG2, but also because they shake up the idea that the
presence of p53 is a good prognostic factor for the patient
response to chemotherapy. Indeed, it does not always
seem to be the case for example if hypoxic conditions are
superimposed to the application of the chemotherapeutic
drug since, in the case of HepG2 cells, it is its inhibition
by hypoxia that leads to chemoresistance. A better under-
standing of the interplay between the apoptosis-inducing
mechanisms and the pro-survival pathways initiated by
hypoxia is thus needed for developing better therapeutic
strategies to treat cancer patients.
Methods
Cell culture and hypoxia incubation
Human hepatoma cells HepG2, human breast adenocar-
cinoma MCF-7 and human pulmonary A549 cells were
maintained in culture in 75-cm2 polystyrene flasks (Cos-
tar) with respectively Dulbecco's modified Eagle's
medium liquid (DMEM), Roswell Park Memorial Insti-
tute (RPMI) or modified Eagle's medium (MEM), contain-
ing 200 U/ml penicillin and 200 µg/ml streptomycin
(Biowhittaker Europe) and 10% of foetal calf serum and
incubated under an atmosphere containing 5% CO2.
For hypoxia experiments (1 % O2), cells were incubated in
serum-free CO2-independent medium (Invitrogen) sup-
plemented with 1 mM L-glutamine (Sigma) with or with-
out etoposide (Sigma) at 50 µM. Normoxic control cells
were incubated in the same conditions but in normal
atmosphere (20 % O2).
LDH release
LDH release was measured with the «cytotoxicity detec-
tion kit» from Roche Molecular Biochemical according to
the manufacturer's protocol. The culture media from incu-
bated cells were removed and centrifuged to pellet the cell
fragments and apoptotic bodies. In order to lyse the cells,
triton ×100 (Merck) at 10 % in DMEM was added on this
pellet as well as on the cells remaining in the wells. The
percentage LDH release was calculated as follows:
LDH activity in medium (1) + LDH activity of cell frag-
ments (2)/(1) + (2) + LDH activity of cells remaining in
the wells.
Caspase 3 activity
The fluorogenic substrate Ac-DEVD-AFC was used to
measure caspase 3 activity according to Lozano et al [35].
Cell extracts were prepared as described by Wellington et
al [36]. Cells were seeded in 6-well plates (250,000 cells/
well for HepG2 and A549 and 200,000 cells/well for
MCF-7). After the incubation, the medium was recovered
and centrifuged at 1,000 g for 5 min. Cells still attached to
the well were scrapped in 200 µl cold PBS and recovered
into a microtube. Pelleted detached cells were resus-
pended in 100 µl PBS at 4°C and also added to the micro-
tube. The samples were centrifuged at 1,000 g for 5 min.
at 4°C and the pellet resuspended in 50 µl of lysis buffer
(10 mM Hepes/KOH, pH 7.0, 10 % sucrose, 2 mM EDTA,
0.1 % CHAPS, 5 mM dithiothreitol and 10 µg/ml apro-
tinin). After incubation at 4°C on a rotating wheel for 15
min, the lysates were centrifuged at 13,000 g for 5 min at
4°C and the supernatants were recovered for the assay.
The protein concentration was measured and 5 µg com-
pleted to 50 µl with lysis buffer were mixed with 13 µM
Ac-DEVD-AFC (BD Pharmingen) and 50 µl reaction
buffer (40 mM PIPES, pH 7.2, 200 mM NaCl, 2 mM
EDTA, 0.2 % CHAPS, 0.10 % sucrose and 10 mM dithio-
threitol). The reaction was allowed to take place for 1 hour
at 37°C and the fluorescence generated by the release of
the fluorogenic group AFC on cleavage by caspase 3 was
measured by excitation at 400 nm and emission at 505
nm.
Western blotting
Cells, seeded in 25 cm2 flasks, were scrapped in 200 µl of
lysis buffer (Tris 40 mM pH 7.5, KCl 150 mM, EDTA 1
mM, triton X-100 1%) containing a protease inhibitor
mixture («Complete» from Roche Molecular Biochemi-Molecular Cancer 2007, 6:61 http://www.molecular-cancer.com/content/6/1/61
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cals, 1 tablet in 2 ml H2O, added at a 1: 25 dilution) and
phosphatase inhibitors (NaVO3 25 mM, PNPP 250 mM,
α-glycerophosphate 250 mM and NaF 125 mM, at a 1: 25
dilution). Western blot analysis was performed as
described in [20] using mouse anti-PARP-1 monoclonal
antibody (#556493 from Pharmingen) as the primary
antibody. Mouse anti-PARP-1 monoclonal antibody
(#556493 from Pharmingen), mouse anti-p53 (#05–224
Upstate), rabbit anti-p53 (SC-6243 Santa Cruz), mouse
anti-phosphorylated serine 15-p53 (#9286 Cell Signal-
ing) and mouse anti-HIF-1α (# 610958 Becton Dickin-
son) were used at 1/5,000 dilution. Sheep anti-mouse or
rabbit IgG horseradish peroxidase-linked antibody
(Amersham Pharmacia Biotech) was used at 1/100,000
dilution as the secondary antibody.
For detection of caspase 3, Bax and p21, samples were
applied to 4–12% NuPAGE Bis-Tris gels with MES buffer
(Invitrogen), according to the manufacturer's instructions
and then, transferred to Hybond-PVDF membrane (Amer-
sham) or nitrocellulose membrane for detecting caspase 3
(BioRad). Membranes were blocked overnight at 4°C in
TBS-Tween 2% blocking agent. Then, membranes were
probed with rabbit anti-caspase 3 antibody (#9662 Cell
Signaling), rabbit anti-p21 antibody (SC-398 Santa Cruz)
or rabbit anti-Bax (#06–499 Upstate) at a final dilution 1/
5,000 overnight at 4°C. After 3 × 15 min washes in TBS-
Tween, the incubation with the secondary antibody was
performed for 45 min in TBS-Tween 2% blocking agent
followed by 3 washes of 15 min in TBS-Tween. Mem-
branes were reprobed with α-tubulin antibody (Sigma,
final dilution 1/50,000) or ERK-2 (BD Transduction labo-
ratories, final dilution 1/5,000) for normalization.
Immunofluorescence staining and confocal microscopy
HepG2 and A549 cells were seeded at 50,000 cells/well
while MCF-7 cells were seeded at 25,000 cells/well on
glass coverslips in 24-well plates and 2 days later were
incubated for different time with or without etoposide
under normoxic or hypoxic conditions Immunofluores-
cence staining was performed as described in [20].
Primary antibodies were as follow : mouse anti-p53 (#05–
224 Upstate) and rabbit anti-phospho-histone H2AX
(#26079 Upstate). Alexa Fluor-568-conjugated anti-
mouse or rabbit IgG antibody (Molecular Probes) were
used at 1/1000 dilution.
Nuclear protein extraction
Nuclear protein extractions in high salt buffer were pre-
pared as previously described [37]. Briefly, cells seeded in
75 cm2 flasks (Corning) were incubated with or without
etoposide under normoxic or hypoxic conditions for 16
hours. At the end of the incubation, cells were rinsed with
PBS containing 1 mM Na2MoO4 and 5 mM NaF and incu-
bated on ice for 3 minutes with 10 ml cold Hypotonic
Buffer (HB, 20 mM HEPES, 5 mM NaF, 1 mM Na2MoO4,
0.1 mM EDTA) and harvested in 500 µl HB containing
0.2% NP-40 (Sigma), a protease inhibitor cocktail
(Roche) and phosphatase inhibitors (1 mM Na3VO4, 5
mM NaF, 10 mM p-nitrophenylphosphate, 10 mM β-glyc-
erophosphate). Cell lysates were centrifuged 30 seconds at
13000 rpm and sedimented nuclei were resuspended in
50  µl HB containing 20% glycerol and protease/phos-
phatase inhibitors. Extraction was performed for 30 min-
utes at 4°C by the addition of 100 µl HB containing 20%
glycerol, 0.8 M NaCl and protease/phosphatase inhibi-
tors.
DNA-binding assay
DNA-binding assays using TransAM ELISA kit (Active
Motif) for detecting transcription factor DNA binding
activity was performed according to the manufacturer's
recommendations. Briefly, 10 µg of nuclear proteins were
incubated for 2 hours in a 96-well plate coated with a dou-
ble-stranded oligonucleotide containing the consensus
sequence recognized by the transcription factor to be
assayed (EPO enhancer sequence for HIF-1α). The tran-
scription factor bound to DNA was detected using a spe-
cific primary antibody (rabbit anti-p53 (SC-6243 Santa
Cruz) and mouse anti-HIF-1α (# 610958 Becton Dickin-
son)). Colorimetric reaction was then performed with a
HRP-conjugated anti-rabbit IgG antibody and absorbance
was measured at 450 nm in a spectrophotometer.
Transient transfection and luciferase assay
Cell transfections were performed in 24-well plates
(50,000 cells per well for HepG2 and A549, 40,000 cells
per well for MCF-7) with SuperFect reagent (Qiagen).
1846 ng of the reporter plasmid pG13-Luc containing 13
copies of a p53-responsive promoter driving the expres-
sion of the luciferase gene [38] were co-transfected with
1154 ng of normalization vector (pCMVb vector coding
for the β-galactosidase, Promega) in DMEM without
serum for 8 hours. Cells were then directly incubated
under hypoxia for 16 hours. After hypoxia incubation, β-
galactosidase was assayed in parallel to the firefly luci-
ferase activity, assayed using the Luciferase Reporter Assay
System (Promega). Experiments were performed in tripli-
cates. Results are expressed as means of the ratio between
the firefly luciferase activity and the β-galactosidase activ-
ity.
Gene expression analysis on DNA microarray
We used a low-density DNA array allowing the gene
expression analysis for 123 genes related to apoptosis
(DualChip® human apoptosis, Eppendorf). Results using
these reliable and validated arrays developed by Eppen-
dorf were reported elsewhere [39-41]. The method is
based on a system with two identical arrays on a glass slideMolecular Cancer 2007, 6:61 http://www.molecular-cancer.com/content/6/1/61
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and three identical sub-arrays (triplicate spots) per array.
HepG2 cells cultured in 75 cm2 flasks (Corning) were
incubated for 16 hours with or without etoposide under
normoxic and hypoxic conditions. At the end of the incu-
bation, total RNA was extracted with the Total RNAgents
extraction kit (Promega), quality was checked with a bio-
analyzer (Agilent Technologies) and 20 µg were used for
retrotranscription in the presence of biotin-11-dCTP (Per-
kin-Elmer) and Superscript II Reverse Transcriptase (InV-
itrogen), as described previously [39]. Hybridizations on
the arrays were carried out as described by the manufac-
turer and reported previously [39]. Detection was per-
formed with a cyanin 3-conjugated IgG anti-biotin
(Jackson Immuno Research Laboratories). Fluorescence of
hybridized arrays was scanned using a Packard ScanArray
(Perkin-Elmer) at a resolution of 10 µm.
Real time RT-PCR
After the incubation, total RNA was extracted using the
Total RNAgent extraction kit (Promega). mRNA con-
tained in 5 µg total RNA was reverse transcribed using
SuperScript II Reverse Transcriptase (InVitrogen) accord-
ing to the manufacturer's instructions. Forward and
reverse primers for MCL-1  (FP:  AAACGGGACT-
GGCTAGTTAAACAA,  RP:  TACTCCAGCAACACCT-
GCAAA), BAK1 (FP: CTTCGTGGTCGACTTCATGCT, RP:
GGACCATTGCCCAAGTTCAG),  GPX1  (FP:  TTCCCGT-
GCAACCAGTTTG, RP: CCGGACGTACTTGAGGGAATT),
CDNK1A  (FP:  CTGGAGACTCTCAGGGTCGAA,  RP:
CCAGGACTGCAGGCTTCCT),  aldolase  (FP:  TGCGCAG-
GAGGAGTATGTCA,  RP:  AGGCGTGGTTAGAGACGAA-
GAG),  GADD45A  (FP:
GGGCTGAGTGAGTTCAACTACATG, RP: GCTTCCTTCT-
TCATTTTCACCTCTT),  GAPDH  (FP:  ACCCACTCCTC-
CACCTTTGAC, RP: GTCCACCACCCTGTTGCTGTA) and
RPL13A (FP: CTCAAGGTCGTGCGTCTGAA, RP: TGGCT-
GTCACTGCCTGGTACT) were designed using the Primer
Express 1.5 software (Applied Biosystem). Amplification
reaction assays contained 1× SYBR Green PCR Mastermix
(Applied Biosystem) and primers (Eurogentec) at the
optimal concentrations. A hot start at 95°C for 5 minutes
was followed by 40 cycles at 95°C for 15 seconds and
65°C for 1 minute using an ABI PRISM 7000 SDS thermal
cycler (Applied Biosystem). RPL13A was used as the refer-
ence gene for normalization and mRNA expression level
was quantified using the threshold cycle method.
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